Dr. Selwyn Vickers, President & CEO of Memorial Sloan Kettering, discusses expanding cancer care and the role of environmental factors. He explores genetic factors in breast, ovarian, prostate, lung, brain, and pancreatic cancer, and the challenges of early detection. The potential impact of weight loss drug, Ozempic, on cancer is also discussed. Dr. Vickers shares his educational background, upbringing, experience with pancreatic cancer surgery, and qualities of a great surgeon.